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Abstract
Background: Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract infections in infants. A
small percentage of the infected infants develops a severe infection, while most of these severely ill patients were
previously healthy. It remains unclear why these children develop severe RSV infections. In this study, we investigate
whether pneumococcal nasopharyngeal carriage patterns correlate with mucosal inflammation and severity of disease.
Methods: In total, 105 infants hospitalized with RSV infection were included and recovery samples were taken from
42 patients. The presence and density of Streptococcus pneumoniae was determined by RT qPCR to study its relation
to viral load, inflammation (MMP-9 and IL-6) and severity of RSV disease.
Results: We show that pneumococcal presence or absence in the nasopharynx does not correlate with viral load,
inflammation or severity of disease. However, when pneumococcus is present in patients, a higher nasopharyngeal
pneumococcal density was correlated with a higher RSV load, higher MMP-9 levels and a less severe course of disease.
Conclusions: Our results show correlations between S. pneumoniae density and viral load, inflammation and disease
severity, suggesting that pneumococcal density may be an indicator for severity in paediatric RSV disease.
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Background
Respiratory syncytial virus (RSV) is a major cause of severe
respiratory infections in infants below 6 months of age and
the most common cause for bronchiolitis. Approximately
60 % of all infants are infected with RSV during their first
winter season and at the age of 2 almost all children have
encountered RSV [1]. The vast majority of children will de-
velop relatively mild symptoms, comparable to a common
cold. However, approximately 2–3 % will develop bronchio-
litis and will be hospitalized [2]. Known risk factors for se-
vere disease are age (<6 months), prematurity, congenital
heart or lung disease and presence of siblings [2–5]. A con-
siderable part of the severely ill patients were previously
healthy and, at this moment, we do not understand why
these children become severely ill.
Mucosal surfaces of the human body are inhabited by
complex microbial ecosystems, together called the
‘microbiome’. A growing body of evidence shows that the
microbiome is crucial for the shaping of our immune sys-
tem [6, 7]. Because an over-exuberant immune response
plays a crucial role in severe RSV infections, the compos-
ition of the microbiome during the first months after birth
should be considered as a potential determinant for severity
of disease upon infection with RSV [8]. Interactions
between RSV and Streptococcus pneumoniae are well-
documented previously. Most of these studies focus on the
influence of RSV infections on secondary pneumococcal in-
fections, e.g. showing an enhanced adherence of S.* Correspondence: gerben.ferwerda@radboudumc.nl
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pneumoniae to RSV-infected cells [9–13]. However,
whether the presence of S. pneumoniae in the nasophar-
ynx may influence a subsequent RSV infection has not
been studied in infants. There are studies showing that S.
pneumoniae may aggravate RSV infections [14, 15]. Cells
infected by pneumococci are more susceptible to RSV in-
fection in vitro and in a mouse model [14]. In a study in
South-Africa, it was shown that vaccination against S.
pneumoniae reduces viral-caused pneumonias by 31 %,
suggesting a promoting role for S. pneumoniae in viral re-
spiratory infections [15]. In this study, the presence and
density of S. pneumoniae was determined in a clinical co-
hort of infants hospitalized with RSV infections. Classic-
ally, severity of an infection is thought to be dependent on
two factors: pathogen load and inflammatory response.
Previous studies have shown that bacterial colonization is
able to influence viral infection rate [16–18], but may also
influence the inflammatory response during an infection
[19–22]. Therefore, we studied correlations between
pneumococcal colonization patterns and RSV load, levels
of the inflammatory mediators IL-6 and MMP-9, both as-
sociated with RSV infection [23–25] as well as S. pneumo-
niae infection [26–28], and severity of disease.
Methods
Study design
Children younger than 2 years of age with laboratory
confirmed RSV infections were prospectively included dur-
ing three consecutive winter seasons (November-April in
2010/2011, 2011/2012 and 2012/2013). Written informed
consent was obtained from all parents. Patients with con-
genital heart or lung disease, immunodeficiency or gluco-
corticoid use were excluded. Medical history, demographics
and clinical parameters were collected from questionnaires
and medical records. Patients were divided into three
groups. Children without hypoxia were classified as ‘mildly
ill’. ‘Moderately ill’ children received supplemental oxygen,
while ‘severely ill’ children required mechanical ventilation.
Within 24 h after admission, a nasopharyngeal aspirate
(NPA) was collected (acute) and parents from hospitalized
children were asked for permission to draw a second NPA
sample 4–6 weeks after admission (recovery). The study
was approved by the Central Committee on Research In-
volving Human Subjects of the Radboud university medical
center.
Sample collection
The nasopharyngeal aspirates were collected by introdu-
cing a catheter, connected to a collection tube and an
aspiration system, into the nasopharyngeal cavity. Then,
0.5 ml of saline was instilled into the catheter and, while
slowly retracting the catheter, the nasopharyngeal fluid
was aspirated in a collection tube. Afterwards the cath-
eter was flushed with 1 ml of saline and this was added
to the collection fluid. Samples were kept cold and were
immediately transferred to the laboratory. Samples were
taken for viral and bacterial diagnostics. For viral diagnos-
tics samples were analyzed by multiplex PCR, quantifying
15 different viral pathogens, as previously described [29].
The remaining NPA was centrifuged at 500*g for 10 min
at 4 °C to spin down the mucus and cells, after which the
supernatant was frozen at −80 °C for ELISA.
Bacterial diagnostics
Nasopharyngeal aspirates (300 μl) were resuspended in
343 μl lysis buffer (AGOWA mag Mini DNA Isolation
Kit, AGOWA) with 57 μl protease. Then, 25–50 mg ster-
ile zirconium beads were added and 500 μl phenol. The
samples were disrupted using the TissueLyser (Qiagen) for
2 min, twice. The samples were then centrifuged for
10 min at 10,000 rpm and the supernatant containing the
released DNA was then purified according to the protocol
included in the AGOWA mag Mini DNA Isolation Kit, as
described previously [30]. Samples were resuspended in
50 μl elution buffer and stored at −80 °C until further use.
RT qPCR was used to quantify total bacterial carriage
density (16 s), S. pneumoniae (Sp), and H. influenzae (Hi)
by amplifying the 16 s rRNA gene, the lytA gene and the
hpd gene, respectively, as previously described [30].
Primers and probes used can be found in Additional file 1:
Table S1. All samples were run in duplicate. Samples were
analyzed on a Bio-Rad CFX96 Real-Time System. Primer
and probe concentrations were optimized for each target
and the machine. Final primer/probe concentrations were
5 nM for 16 s, 200 nM for lytA (Sp) and 300 nM for hpd
(Hi). 0.8 μl of each primer and/or probe was added to a
20 μl reaction volume. Standard curves were created using
purified genomic DNA extracted from laboratory refer-
ence strains and quantified using the NanoDrop ND-
1000. For S. pneumoniae, DNA was extracted from TIGR4
[31]. For H. influenzae, DNA was extracted from R2866
[32]. As a measure for bacterial density, we deter-
mined the number of bacterial genomes per ml of NPA.
We used the following formula: Number of genome copies
per μl of extracted DNA= (mass in ng * Avagadro’s
number)/(genome length for each bacteria * 109 * 650). 650
daltons is the average weight of a DNA basepair. We then
multiplied this number by 167 to account for the difference
between the volume of nasal wash used in the extraction
(300 μl) and the volume of extracted DNA (50 μl) in order
to determine genome copies per ml of NPA [30]. As a
negative control, a water sample was included during the
whole procedure from DNA isolation to RT qPCR. For the
specific bacterial RT qPCR’s Ct values above 35 were
regarded as negative, based on the negative controls. For
the 16 s RT qPCR, Ct values above 30 were regarded as
negative.
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Inflammatory markers
MMP-9 concentrations were measured in the nasopha-
ryngeal aspirates using R&D ELISA kits (R&D systems)
according to the instructions of the manufacturer. Sam-
ples were 10,000x diluted for the MMP-9 ELISA, which
therefore had a lower detection limit of 156 ng/ml. IL-6
concentrations were measured using a Sanquin ELISA
kit according to the instructions of the manufacturer.
Samples were 100-fold diluted and therefore the IL-6
ELISA had a lower detection limit of 156 pg/ml.
Statistical analysis
Values are expressed as percentages for categorical variables
and as median and interquartile range (IQR) for continuous
variables. Chi-squared tests were performed to compare
categorical data between multiple groups. When significant
differences were identified, Fisher’s exact tests were per-
formed to specify which groups differed. As tested by
Shapiro-Wilk’s test, none of the continuous variables were
normally distributed. Therefore, Kruskal–Wallis H tests
were used to compare continuous data between multiple
groups. When significant differences were found, Mann–
Whitney U tests were performed to specify which groups
differed. To determine whether correlations existed, a
Spearman correlation test was performed. A value of
p < 0.05 was considered statistically significant. All
statistical analyses were conducted in GraphPad Prism
5.03 or IBM SPSS Statistics 20.
Results
Patient characteristics
In total, 105 RSV-infected infants were included. From
these 105 RSV infected patients, 25 patients were catego-
rized as mildly ill meaning there was no need for oxygen
support, 53 patients were moderately ill and required
oxygen support, 27 patients were severely ill necessitating
mechanical ventilation. Significant differences between the
severity groups were found for known risk factors like age
and presence of siblings, but also for hospital duration, day-
care attendance, vaccination status and viral co-infections
(Table 1).
Presence of S. pneumoniae does not correlate with viral
load, inflammation or disease severity
In all collected samples, 16 s rRNA could be detected by
RT qPCR. Samples could therefore be used for add-
itional analysis (data not shown). First, we studied
whether pneumococcal colonization influenced RSV in-
fection. There were no significant differences between the
pneumococcal positive group compared to the pneumo-
coccal negative group, regarding viral load (Fig. 1a). This
was also the case for the inflammatory mediators, MMP-9
and IL-6 (Fig. 1b). When looking at severity scores, the
moderately ill infants had a higher percentage of pneumo-
coccal positive infants compared to the mildly ill infants
(Fig. 1c). However, we did not see this trend for the severe
group.
In conclusion, we detected no correlation between the
presence of S. pneumoniae and viral load, inflammation
or severity of disease. As shown in Table 1, age is an im-
portant potential confounder. Therefore, we checked
whether pneumococcal colonization was correlated with
age (Additional file 1: Figure S1A). Some significant dif-
ferences were found between the different age groups
but no clear trends were found. The same analyses were
performed for another potentially pathogenic nasopha-
ryngeal bacterium (Haemophilus influenzae) to see if the
effects found were specific for S. pneumoniae. No signifi-
cant differences regarding viral load, inflammation and
severity were found for H. influenzae (Additional file 1:
Figure S2). Colonization with H. influenzae was also not
age-dependent (Additional file 1: Figure S1B).








Age (days) (median + IQR)a 191 (73–538) 134 (58–323) 38 (19–55) <0.001
Gestational age (weeks) (median + IQR)a 39 (37–40) 39 (37–40) 38 (37–39) NS
Male (%) 60 52 57 NS
Hospital duration (days) (median + IQR)a 1 (0–5) 6 (4–9) 11 (10–14) <0.001
Siblings (%) 60 79 89 0.037
Daycare (%) 68 50 15 0.001
Antibiotics in past 4 weeks (%) 28 8 19 NS
Vaccination according to Dutch immunisation program (%) 84 79 19 <0.001
RSV load (Ct value) (median + IQR)a 22 (21–27) 24 (22–30) 23 (21–27) NS
Viral co-infection (%) 64 46 21 0.007
Data are presented as median + interquartile range (IQR) for continuous variables or in percentages for categorical variables. aShapiro–Wilk’s test was used to test
data normality for continuous variables. Age, gestational age, hospital duration and RSV load were not normally distributed and therefore a Kruskal–Wallis H test
was used for continuous variables. Categorical variables where tested using Chi-square analysis
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Pneumoccocal density correlates with viral load,
inflammation and severity
As we did not see any differences between patients with or
without pneumococcus, we then focussed on the patients
that were pneumococci positive. We studied whether
pneumococcal density influences RSV infection. When cor-
relating pneumococcal density with RSV load, we found
that a higher density of S. pneumoniae was correlated with
higher titers of RSV (Fig. 2a). This also holds true for
MMP-9, for which a higher S. pneumoniae density corre-
lated with higher concentrations of MMP-9 (Fig. 2b). In
contrast, IL-6 did not correlate with pneumococcal dens-
ity (Fig. 2b). Lastly, we also compared the different severity
groups and found that more severely infected infants had
lower pneumococcal densities (Fig. 2c). In addition,
pneumococcal density was not significantly different be-
tween the different age groups (Additional file 1: Figure
S3A) and therefore not age-dependent.
H. influenzae was also included, but no significant differ-
ences were found (Additional file 1: Figure S4) and H. influ-
enzae density was not age-dependent (Additional file 1:
Figure S3B). These results indicate that the effects found
are specific for S. pneumoniae.
Pneumococcal colonization and density does not change
after RSV infection
Additionally, 42 of the patients were also sampled 4–6
weeks after hospital discharge. Because viral respiratory
infections are known to increase the risk of bacterial infec-
tions, we investigated whether pneumococcal colonization
rates and density change after an RSV infection. Percent-
ages of colonization were identical when comparing the
acute and recovery group (Fig. 3a). Therefore, RSV in-
fection did not change colonization rates in infants.
Also, pneumococcal density of the pneumococcal posi-
tive patients was not significantly different between
patients having an infection and patients in the recov-
ery phase (Fig. 3b). Lastly, when we looked at the shifts
in colonization, we saw that 25 % of the infants was not
colonized during the acute infection and remained so
during the recovery phase (Fig. 3c). Also, approximately
the same number of infants acquired S. pneumoniae after
an RSV infection as the number losing S. pneumoniae.
Discussion
This study is the first to report that S. pneumoniae density
in the nasopharynx is correlated with viral load, inflamma-
tory conditions and severity during RSV infection of hospi-
talized infants. We here show that pneumococcal carriage
density is lower during severe RSV infections and that a
low density correlates with a low RSV load and low levels
of MMP-9. This indicates that S. pneumoniae colonization
during RSV infection is associated with viral infection and
Fig. 1 Pneumococcal presence does not correlate with RSV load,
inflammation or disease severity. Viral load (a) and MMP-9 and IL-6 (b)
were compared between the group positive for S. pneumoniae and the
group negative for S. pneumoniae. Data shown are median ± IQR. Data
were tested for significant differences using a Mann–Whitney U test.
Pneumococcal presence was compared between the three severity
groups (c). Differences in bacterial colonization rates were compared
using Chi-square tests. When significant differences were found, Fisher’s
exact tests were performed to specify which groups differed significantly.
The moderately ill infants had a significantly higher colonization rate
compared to the mildly infected infants (***p< 0.001)
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the inflammatory response and therefore could influence
the development of disease.
We used RT qPCR to determine bacterial carriage dens-
ity instead of culturing methods. RT qPCR is faster and
more sensitive than culturing techniques, especially when
samples have to be frozen [33, 34]. Good correlations have
been reported for S. pneumoniae and H. influenzae when
comparing RT qPCR with quantitative culturing [35]. One
important drawback of RT qPCR is that viable and nonvia-
ble bacteria cannot be distinguished. However, for our
study, this is an advantage as it more accurately detects the
presence of bacterial pathogens without any disturbance
due to recent antibiotic treatment. In the Netherlands,
patients with severe infections, who require mechanical
ventilation, receive selective decontamination of the digest-
ive tract (SDD) by use of antibiotics. Our study subjects
were sampled within 24 h after admission to the hospital.
Therefore, we do not expect that the SDD regimen will
have exerted an effect on bacterial carriage density mea-
sured by RT qPCR. Moreover, if SDD antibiotics would
Fig. 2 Pneumococcal density correlates with RSV load, inflammation and severity. Pneumococcal density was correlated with viral load (a) and MMP-9
and IL-6 levels (b). Correlations were tested for significance using a Spearman correlation test. Pneumococcal density was compared between the three
severity groups (c). Data shown are median ± IQR. Differences in bacterial carriage density are tested using a Kruskal-Wallis test. When significant differences
were found, Mann–Whitney U tests were performed to specify which groups differed (*p< 0.05, **p< 0.01)
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have such rapid effects, one would also expect to see the
same trends for H. influenzae, but this is not the case.
A recent study has shown that antibiotics given in the
week prior to sampling reduced colonization rates of poten-
tial pathogenic bacteria, e.g. S. pneumoniae, M. catarrhalis,
H. influenzae, S. aureus and β-hemolytic Streptococcus but
had no clear effect on paediatric RSV disease severity scores
[36]. In our study, we determined whether infants received
antibiotic treatment in the 4 weeks prior to hospitalization.
No significant differences were found in pneumococcal
colonization or severity status (data not shown).
We included a control group of infants who were
hospitalized for a hernia operation to check how the in-
flammatory mediators behave in different groups. We
see different dynamics for MMP-9 and IL-6 (Additional
file 1: Figure S5). IL-6 is only elevated during the acute
phase of disease, whereas MMP-9 is elevated both dur-
ing the acute phase of disease and the recovery phase.
To our knowledge, we are the first to show a negative
correlation between RSV disease severity and pneumo-
coccal carriage density. Clinical studies have shown that
the pneumococcal conjugate vaccine also results in a
reduction of 31 % of the viral respiratory tract infections
[15, 37]. This suggests that colonization with S. pneumo-
niae increases the risk of viral infection or that its pres-
ence enhances symptoms. However, our study shows
that severely ill patients have lower pneumococcal car-
riage density, thus suggesting that high S. pneumoniae
density protects against severe infections.
S. pneumoniae and RSV are known to influence each
other [38]. In vitro studies have shown that RSV infection
of respiratory epithelial cells enhances the adherence of S.
pneumoniae, possibly because the RSV G protein can
serve as a receptor for S. pneumoniae [9, 12]. This is in
accordance with our observation that higher RSV loads
coincide with higher pneumococcal carriage density.
MMP-9 is a matrix metalloproteinase which is involved
in breakdown of extracellular matrix and appears to be a
regulatory factor in neutrophil migration across the base-
ment membrane [39]. High MMP-9 concentrations have
been associated with severe RSV infections [24]. Studies
have shown that RSV is able to induce MMP-9 production
[40]. However, in our study no correlation was found
between MMP-9 levels and RSV load (data not shown).
Previously, we have shown that S. pneumoniae is able to
induce high MMP-9 levels under in vitro conditions [26].
This is supported by this study where we show a correlation
between pneumococcal carriage density and MMP-9 levels,
in which higher numbers of S. pneumoniae led to higher
concentrations of MMP-9.
All our data together suggest that severely ill infants
have lower pneumococcal loads, these lower pneumo-
coccal loads are correlated with lower RSV levels and
lower MMP-9 levels. However, this suggests indirectly
that severely ill infants have lower RSV levels, which
seems contradictory. Although the general consensus is
that viral load is probably correlated with disease sever-
ity, there is still discussion to what extent [41–44]. Our
data do not show a correlation between RSV load and
disease severity (Table 1). A possible explanation for this
discrepancy in our results is that at the moment the
infants are included, they are in an advanced stage of
disease. It is therefore possible that in the severe cases the
virus has already partly been cleared and that severe in-
flammation is cause of the severity, not viral load. Another
explanation is that the interactions between S. pneumoniae,
Fig. 3 Pneumococcal colonization and density does not change after RSV infection. Pneumococcal colonization rate, density and shifts were
compared between the acute and the recovery group. Differences in bacterial colonization rates were compared using a Fisher’s exact test of all
patients that had an acute and recovery sample taken (a). Differences in bacterial density between de pneumococcal positive samples were
compared using a Mann–Whitney U test. Data shown are median ± IQR (b). Shifts in pneumococcal density between all acute and recovery
samples are shown (c)
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RSV load, inflammation and disease severity are multidir-
ectional and more complex than we can grasp in this
study. Other factors, that we did not include in this study,
could play a role. We did carefully evaluated the presence
of potential confounders that may explain the results of
our study. When comparing severity groups, the severe
groups had a lower daycare attendance and lower vaccin-
ation rates. These are both due to the fact that the severely
ill patients were often too young for vaccination and day-
care attendance. The severely infected patients also had
more siblings, which is a known risk factor for severe RSV
infections [4, 45]. Vaccination, daycare attendance and
presence of siblings can all influence pneumococcal
carriage patterns. However, the severely infected in-
fants did not yet receive pneumococcal vaccination
and had more siblings. This would all have resulted
in a higher pneumococcal load instead of a lower
load. We cannot exclude that less daycare attendance
in the severely infected infants may have contributed
to lower pneumococcal carriage. Patients with severe
infections had more RSV mono-infections compared
to the other severity groups. This was already shown
by our group in a previous cohort [3]. Finally, age
could be a confounder as the severely ill patients are
significantly younger compared to the moderate or
mildly ill patients. As we have shown in Additional
file 1: Figure S1 and S3, S. pneumoniae and H. influ-
enzae carriage densities were not dependent on age,
whereas the densities of S. aureus and M. catarrhalis
were age dependent (data not shown).
There are some limitations to our study. Based on the
study design we cannot state anything on causality. We do
not know whether pneumococcal density changes as a
result of RSV infection, or whether the pneumococcal
density was already different and potentially influenced
susceptibility to an RSV infection. A prospective study is
needed to definitely determine whether S. pneumoniae
influences RSV severity. Moreover, there is a difference
between absolute density and relative abundance. We did
not look at the influence of relative abundance of S.
pneumoniae.
Conclusions
In summary, we here show that S. pneumoniae dens-
ity correlates to disease severity, viral load and in-
flammatory mediators, which suggests that S.
pneumoniae density influences both viral load as well
as the mucosal inflammatory response during an RSV
infection. Once we understand the role of different
bacteria residing in the upper respiratory tract in se-
verity of RSV infections, we might be able to predict
severity or modify the composition of the microbiome
to prevent severe infections.
Additional file
Additional file 1: Table S1. Primers and probes used for RT qPCR
assays. Figure S1. No clear age dependent colonization patterns were
found for S. pneumoniae (A) and H. influenza (B). Figure S2. H.
influenzae presence does not influence RSV load, inflammation or
severity. Figure S3. S. pneumoniae (A) and H. influenza (B) density are
not age dependent. Figure S4. H. influenzae density does not influence
RSV load, inflammation and severity. Figure S5. IL-6 levels are elevated
during acute phase of disease, whereas MMP-9 is elevated during acute
and recovery phase of disease. (PDF 2 MB)
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